A new study from Baylor College of Medicine targets specific proteins that cause tumor growth as a potential personalized treatment for breast cancer.
The collaboration by researchers at Baylor College of Medicine, Washington University School of Medicine and the Broad Institute of MIT and Harvard have developed a new method to treat breast cancer by targeting the specific proteins that are responsible for tumor growth and test drugs that can neutralize the biological drivers.
